Announcements

Aurinia Pharmaceuticals Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, disclosing net income of $37.4 million for the second quarter and $71.8 million for the first half of 2026.

CRA International, Inc. filed a Form 8-K with the SEC on August 6, 2026, disclosing financial results for its fiscal quarter ended July 4, 2026, a quarterly cash dividend declaration, and an increase and extension to its existing credit facility.

CRA International, Inc. filed its Form 10-Q for the fiscal quarter ended July 4, 2026 with the U.S. Securities and Exchange Commission, reporting second-quarter and year-to-date financial results for fiscal 2026.

Oyster Enterprises II Acquisition Corp, a Cayman Islands exempted special purpose acquisition company listed on The Nasdaq Stock Market LLC, filed its quarterly report on Form 10-Q for the period ended June 30, 2026 on August 6, 2026.

Praxis Precision Medicine, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 6, 2026, covering the quarterly period ended June 30, 2026.

Valaris Limited filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 6, 2026, covering the quarterly period ended June 30, 2026.

CG Oncology, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 6, 2026, covering the three- and six-month periods ended June 30, 2026.